Wills Eye Hospital Company Research Report

Company Overview

• Name: Wills Eye Hospital

• Mission: Dedicated to the preservation of sight and the elimination of avoidable blindness.

• Founded: 1832

• Founder: Established as a trust by James Wills, a Quaker merchant.

• Key People:

• Julia A. Haller, MD, Ophthalmologist-in-Chief

• Joseph P. Bilson, Chief Executive Officer

• Bernard W. Smalley Esq., President, Board of Directors of City Trusts

• Headquarters: 840 Walnut Street, Philadelphia, PA 19107

• Number of Employees: No information is available

• Revenue: No information is available

• Notable For:

• Consistently ranked among the best ophthalmology hospitals in the United States.

• Known for having the most nationally ranked ophthalmologists.

• Providing comprehensive ophthalmic medical services and advancing eye research.

Products and Services

Wills Eye Hospital offers a full range of primary and subspecialty eye care, including diagnosis, treatment, and surgery for various conditions. Key services include:

• Cataract & Primary Eye Care: Comprehensive eye examinations, evaluations, and surgical care.

• Cornea: Treatment of cornea diseases and advanced surgical procedures such as LASIK and PRK.

• Glaucoma: Cutting-edge surgical techniques and therapies, along with extensive research.

• Neuro-Ophthalmology: Specialized in optic neuritis, thyroid-related eye disease, and other conditions.

• Ocular Oncology: Largest eye cancer center in the US, treating common and rare cancers.

• Ocular Pathology: Diagnosis and research services with advanced diagnostic methods.

• Oculoplastic & Orbital Surgery: Treatment includes trauma, thyroid eye disease, and cosmetic surgery.

• Pediatric Ophthalmology & Strabismus: Treats a wide range of pediatric eye conditions.

• Retina: Expertise in retinal diseases and surgeries, with involvement in treatment development.

Recent Developments

• Research and Partnerships:

• Vickie and Jack Farber Vision Research Center: Established with a $5 million gift to support vision research, focusing on data mining and analytics, tele-ophthalmology, and more.

• NIH Award: $6.2 million received for vision research in glaucoma.

• Collaboration with Vickie and Jack Farber Institute for Neuroscience at Thomas Jefferson University to advance understanding and cures for eye-related diseases.

• Rankings and Recognition:

• Consistently ranked as one of the top eye hospitals by U.S. News & World Report.

• Annual recognition of doctors as "Top Doctors" by Philadelphia Magazine.

• Clinical Trials and Innovations:

• Participation in multi-site clinical trials for electrical stimulation therapy as an approach to vision loss in glaucoma and other optic neuropathies.

• Continued expansion of research initiatives and a dedicated clinical trials unit.

• Product/Service Enhancements: No specific information is available on new products or service features.

• Partnerships: Continuation and expansion of collaboration with the Farber Institute for Neuroscience.

With a foundation deeply rooted in advanced patient care and innovative research, Wills Eye Hospital maintains its position as a global leader in ophthalmology and a pioneer in medical education and research.